Literature DB >> 28209618

The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer.

Min-Wei Chen1, Shu-Ting Yang2, Ming-Hsien Chien3,4, Kuo-Tai Hua5, Chin-Jui Wu6, S M Hsiao7, Hao Lin8, Michael Hsiao9, Jen-Liang Su10,11,12,13, Lin-Hung Wei14,6.   

Abstract

Ovarian cancer spheroids constitute a metastatic niche for transcoelomic spread that also engenders drug resistance. Spheroid-forming cells express active STAT3 signaling and display stem cell-like properties that may contribute to ovarian tumor progression. In this study, we show that STAT3 is hyperactivated in ovarian cancer spheroids and that STAT3 disruption in this setting is sufficient to relieve chemoresistance. In an NSG murine model of human ovarian cancer, STAT3 signaling regulated spheroid formation and self-renewal properties, whereas STAT3 attenuation reduced tumorigenicity. Mechanistic investigations revealed that Wnt signaling was required for STAT3-mediated spheroid formation. Notably, the Wnt antagonist DKK1 was the most strikingly upregulated gene in response to STAT3 attenuation in ovarian cancer cells. STAT3 signaling maintained stemness and interconnected Wnt/β-catenin signaling via the miR-92a/DKK1-regulatory pathways. Targeting STAT3 in combination with paclitaxel synergistically reduced peritoneal seeding and prolonged survival in a murine model of intraperitoneal ovarian cancer. Overall, our findings define a STAT3-miR-92a-DKK1 pathway in the generation of cancer stem-like cells in ovarian tumors, with potential therapeutic applications in blocking their progression. Cancer Res; 77(8); 1955-67. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28209618     DOI: 10.1158/0008-5472.CAN-16-1115

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  62 in total

1.  MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma.

Authors:  Alex Panaccione; Yi Zhang; Molly Ryan; Christopher A Moskaluk; Karen S Anderson; Wendell G Yarbrough; Sergey V Ivanov
Journal:  Stem Cell Res       Date:  2017-05-05       Impact factor: 2.020

2.  Transcriptomic analysis reveals tumor stage- or grade-dependent expression of miRNAs in serous ovarian cancer.

Authors:  Caglar Berkel; Ercan Cacan
Journal:  Hum Cell       Date:  2021-02-12       Impact factor: 4.174

Review 3.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

4.  MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways.

Authors:  Blanca Majem; Alfonso Parrilla; Carlos Jiménez; Leticia Suárez-Cabrera; Marta Barber; Andrea Marín; Josep Castellví; Gabriel Tamayo; Gema Moreno-Bueno; Jordi Ponce; Xavier Matias-Guiu; Francesc Alameda; Ignacio Romero; José Luis Sánchez; Asunción Pérez-Benavente; Sebastián Moran; Manel Esteller; Jaume Reventós; Marina Rigau; Antonio Gil-Moreno; Miguel F Segura; Anna Santamaría
Journal:  Oncogene       Date:  2019-07-05       Impact factor: 9.867

5.  MicroRNA-92 Expression in CD133+ Melanoma Stem Cells Regulates Immunosuppression in the Tumor Microenvironment via Integrin-Dependent Activation of TGFβ.

Authors:  Chris Shidal; Narendra P Singh; Prakash Nagarkatti; Mitzi Nagarkatti
Journal:  Cancer Res       Date:  2019-04-23       Impact factor: 12.701

6.  Cancer Stem Cells: An Ever-Hiding Foe.

Authors:  Jacek R Wilczyński
Journal:  Exp Suppl       Date:  2022

Review 7.  The Roles of MicroRNA-133 in Gynecological Tumors.

Authors:  Yang Zhou; Zhongping Cheng
Journal:  Gynecol Minim Invasive Ther       Date:  2022-05-04

8.  Molecular imaging-monitored radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus-thymidine kinase gene therapy for rat orthotopic ovarian cancer.

Authors:  Yaying Li; Shuhui Zhao; Feng Zhang; Guangxin Jin; Yiming Zhou; Peicheng Li; David Shin; Xiaoming Yang
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

9.  STAT3/PIAS3 Levels Serve as "Early Signature" Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube.

Authors:  Uksha Saini; Adrian A Suarez; Shan Naidu; John J Wallbillich; Kristin Bixel; Ross A Wanner; Jason Bice; Raleigh D Kladney; Jenny Lester; Beth Y Karlan; Paul J Goodfellow; David E Cohn; Karuppaiyah Selvendiran
Journal:  Cancer Res       Date:  2018-01-16       Impact factor: 12.701

10.  Stat3 loss in mesenchymal progenitors causes Job syndrome-like skeletal defects by reducing Wnt/β-catenin signaling.

Authors:  Prem Swaroop Yadav; Shuhao Feng; Qian Cong; Hanjun Kim; Yuchen Liu; Yingzi Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.